Aurinia Announces LUPKYNIS (voclosporin) Patent Challenge Settlement Reached With Sun Pharmaceuticals (Aurinia Pharmaceuticals Press Release) - Jan 3, 2023 - "Aurinia Pharmaceuticals...announces it has entered into a settlement agreement with Sun Pharmaceutical Industries...that involves both Aurinia and Sun Pharmaceuticals filing a joint motion to terminate the ongoing Inter Partes Review (IPR) directed at Aurinia's U.S. Patent No. 10,286,036, as well as settlement of the ongoing patent infringement litigation in the United States (U.S.) related to Sun's CEQUA® product. Under the settlement agreement, which is contingent upon the U.S. Patent Trial and Appeal Board approving the joint motion to terminate the IPR..."
Patent • Lupus • Lupus Nephritis • Ophthalmology
|